who offers tirzepatide near me (Month 1) 2.5mg Tirzepatide Weight Loss Injections &

Commenting on the findings, study author Edy Kornelius, MD, PhD, of Chung Shan Medical University in Taichung, Taiwan, said, Additional randomised, controlled trials that follow people over time are needed to confirm these findings, but these results are promising, since people with diabetes are at increased risk for developing epilepsy later in life. He added, Epilepsy can have many physical, psychological and social consequences, and many people do not respond to the current medications, so finding ways to reduce this risk is critical. The researchers emphasised that the study does not prove that GLP-1 drugs prevent epilepsy, but rather highlights a potential association that merits further investigation

Int J Clin Pharmacol Ther Toxicol

The change from baseline to end of treatment in body weight was an additional secondary endpoint

15.5% for semaglutide monotherapy at 72 weeks

15, Sept